Tirzepatide injections, also known as Zepbound, have been approved in Canada for the treatment of obstructive sleep apnea in adults with obesity. The treatment has been reported to cause weight loss and improve sleep apnea symptoms. A national campaign has been launched to raise awareness about the treatment, with some outlets providing information on the medication and its potential benefits for sleep apnea.